Inflammatory mediators and signaling components

Inflammatory mediators and signaling components represent a vast array of molecules that initiate, amplify, and regulate the inflammatory response. This group includes secreted signaling proteins such as cytokines (e.g., TNF-alpha, IL-6) and chemokines, as well as the intracellular machinery required to process these signals, including kinases like Janus kinases (JAKs) and transcription factors like NF-kappaB (StatPearls, 2023). While these components are essential for host defense and tissue repair, their chronic overactivation is a hallmark of numerous pathologies, including rheumatoid arthritis, inflammatory bowel disease, and psoriasis (Nature Reviews Drug Discovery, 2017). Pharmacological intervention typically involves neutralizing specific mediators with monoclonal antibodies or blocking signaling nodes with small-molecule inhibitors (PubMed, 2021). However, because this term encompasses hundreds of distinct proteins across multiple pathways, it is classified as a broad functional category rather than a single, well-defined therapeutic target.

Other names

Inflammatory signaling pathwaysPro-inflammatory mediatorsInflammatory cascadeInflammatory signaling molecules

Drugs targeting these components typically act through the neutralization of circulating cytokines, competitive antagonism of cell-surface receptors, or the inhibition of intracellular signaling enzymes such as kinases.